LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: Influence of Lipid Composition of Cationic Liposomes 2X3-DOPE on mRNA Delivery into Eukaryotic Cells.

    Vysochinskaya, Vera / Shishlyannikov, Sergey / Zabrodskaya, Yana / Shmendel, Elena / Klotchenko, Sergey / Dobrovolskaya, Olga / Gavrilova, Nina / Makarova, Darya / Plotnikova, Marina / Elpaeva, Ekaterina / Gorshkov, Andrey / Moshkoff, Dmitry / Maslov, Mikhail / Vasin, Andrey

    Pharmaceutics

    2022  Volume 15, Issue 1

    Abstract: The design of cationic liposomes for efficient mRNA delivery can significantly improve mRNA-based therapies. Lipoplexes based on polycationic lipid 1,26-bis(cholest-5-en-3β-yloxycarbonylamino)-7,11,16,20-tetraazahexacosane tetrahydrochloride (2X3) and ... ...

    Abstract The design of cationic liposomes for efficient mRNA delivery can significantly improve mRNA-based therapies. Lipoplexes based on polycationic lipid 1,26-bis(cholest-5-en-3β-yloxycarbonylamino)-7,11,16,20-tetraazahexacosane tetrahydrochloride (2X3) and helper lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) were formulated in different molar ratios (1:1, 1:2, 1:3) to efficiently deliver model mRNAs to BHK-21 and A549. The objective of this study was to examine the effect of 2X3-DOPE composition as well as lipid-to-mRNA ratio (amino-to-phosphate group ratio, N/P) on mRNA transfection. We found that lipoplex-mediated transfection efficiency depends on both liposome composition and the N/P ratio. Lipoplexes with an N/P ratio of 10/1 showed nanometric hydrodynamic size, positive ζ potential, maximum loading, and transfection efficiency. Liposomes 2X3-DOPE (1:3) provided the superior delivery of both mRNA coding firefly luciferase and mRNA-eGFP into BHK-21 cells and A549 cells, compared with commercial Lipofectamine MessengerMax.
    Language English
    Publishing date 2022-12-20
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527217-2
    ISSN 1999-4923
    ISSN 1999-4923
    DOI 10.3390/pharmaceutics15010008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Treatment of high fracture risk patients in routine clinical practice.

    Lesnyak, Olga / Gladkova, Elena / Aleksandrov, Nikolay / Belaya, Zhanna / Belova, Ksenia / Bezlyudnaya, Natalya / Dobrovolskaya, Olga / Dreval, Alexandr / Ershova, Olga / Grebennikova, Tatiana / Kryukova, Irina / Mazurenko, Sergey / Priymak, Diana / Rozhinskaya, Ludmila / Samigullina, Rusanna / Solodovnikov, Alexander / Toroptsova, Natalya

    Archives of osteoporosis

    2020  Volume 15, Issue 1, Page(s) 184

    Abstract: A retrospective cohort study determined the high incidence of recurrent fractures in osteoporotic patients with high fracture risk during the observation. The strategy of starting treatment with more potent regimens (zoledronic acid, denosumab and/or ... ...

    Abstract A retrospective cohort study determined the high incidence of recurrent fractures in osteoporotic patients with high fracture risk during the observation. The strategy of starting treatment with more potent regimens (zoledronic acid, denosumab and/or teriparatide) seems to have the best secondary fracture prevention efficacy.
    Objective: This paper describes the various medical therapy regimens prescribed to osteoporotic patients with high fracture risk and the result of treatment.
    Methods: We carried out a retrospective cohort study in selected Osteoporosis Centers. Patients were considered to have high fracture risk in case of a history of a low-energy hip fracture or two or more vertebral or other site fractures. A total of 812 subjects (768 women and 44 men) aged 36-95 years were included. The observation period was 2285.1 patient-years. Demographic data, clinical findings, and BMD data obtained by DXA, as well as a history of fractures that had occurred during the follow-up, were included in the analysis.
    Results: Overall, at baseline, there were 637 non-vertebral fractures including 104 hip fractures. A total of 590 patients had vertebral fractures; of these, 69% suffered multiple fractures. Being on treatment, 119 (14.7%) patients developed new vertebral and non-vertebral fractures. The incidence of new non-vertebral fractures and hip fractures was 39.4 and 13.1 per 1000 patient-years. The total number of vertebral fractures increased by 24.8% from 1353 to 1689. The best results of the treatment were achieved in patients who were started on zoledronic acid, denosumab, or teriparatide and had an adequate duration of treatment. Although these patients had significantly lower BMD values at the time of diagnosis compared with other patients, they showed a lower incidence of new vertebral and hip fractures, during the follow-up.
    Conclusion: Therapy of patients at high risk of fractures started with more potent treatment regimens (zoledronic acid, denosumab and/or teriparatide) of adequate duration was more effective in terms of prevention of new vertebral and hip fractures as compared with other treatment options. However, treatment appears to be challenging given the number of recurrent fractures in patients on treatment and the frequency of drug withdrawal or replacement.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Bone Density ; Bone Density Conservation Agents/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Osteoporosis, Postmenopausal ; Osteoporotic Fractures/drug therapy ; Osteoporotic Fractures/epidemiology ; Osteoporotic Fractures/prevention & control ; Retrospective Studies ; Spinal Fractures/epidemiology ; Spinal Fractures/prevention & control ; Teriparatide/therapeutic use
    Chemical Substances Bone Density Conservation Agents ; Teriparatide (10T9CSU89I)
    Language English
    Publishing date 2020-11-20
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2253231-6
    ISSN 1862-3514 ; 1862-3522
    ISSN (online) 1862-3514
    ISSN 1862-3522
    DOI 10.1007/s11657-020-00851-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Quality of life after fragility fracture in the Russian Federation: results from the Russian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (ICUROS).

    Lesnyak, Olga / Svedbom, Axel / Belova, Ksenia / Dobrovolskaya, Olga / Ershova, Olga / Golubev, Georgij / Grebenshikov, Vyacheslav / Ivanov, Sergej / Kochish, Alexander / Menshikova, Larissa / Nikitinskaya, Oxana / Nurligayanov, Radik / Solodovnikov, Alexander / Toroptsova, Natalia / Varavko, Julia / Zotkin, Eugenij / Borgstrom, Fredrik / Kanis, John A

    Archives of osteoporosis

    2020  Volume 15, Issue 1, Page(s) 37

    Abstract: Changes in health-related quality of life (QoL) due to hip, humeral, ankle, spine, and distal forearm fracture were measured in Russian adults age 50 years or more over the first 18 months after fracture. The accumulated mean QoL loss after hip fracture ... ...

    Abstract Changes in health-related quality of life (QoL) due to hip, humeral, ankle, spine, and distal forearm fracture were measured in Russian adults age 50 years or more over the first 18 months after fracture. The accumulated mean QoL loss after hip fracture was 0.5 and significantly greater than after fracture of the distal forearm (0.13), spine (0.21), proximal humerus (0.26), and ankle (0.27).
    Introduction: Data on QoL following osteoporotic fractures in Russia are scarce. The present study evaluated the impact of hip, vertebral, proximal humerus, distal forearm, and ankle fracture up to 18 months after fracture from the Russian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study.
    Methods: Individuals age ≥ 50 years with low-energy-induced humeral, hip, clinical vertebral, ankle, or distal forearm fracture were enrolled. After a recall of pre-fracture status, HRQoL was prospectively collected over 18 months of follow-up using EQ-5D-3L. Multivariate regression analysis was used to identify determinants of QALYs loss.
    Results: At 2 weeks, patients with hip fracture (n = 223) reported the lowest mean health state utility value (HSUV) compared with other fracture sites. Thereafter, utility values increased but remained significantly lower than before fracture. For spine (n = 183), humerus (n = 166), and ankle fractures (n = 214), there was a similar pattern of disutility with a nadir within 2 weeks and a progressive recovery thereafter. The accumulated mean QoL loss after hip fracture was 0.5 and significantly greater than after fracture of the distal forearm (0.13), spine (0.21), proximal humerus (0.26), and ankle (0.27). Substantial impairment in self-care and usual activities immediately after fracture were important predictors of recovery across at all fracture sites.
    Conclusions: Fractures of the hip, vertebral, distal forearm, ankle, and proximal humerus incur substantial loss of QoL in Russia. The utility values derived from this study can be used in future economic evaluations.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Ankle Injuries/economics ; Ankle Injuries/psychology ; Cost of Illness ; Female ; Forearm Injuries/economics ; Forearm Injuries/psychology ; Hip Fractures/economics ; Hip Fractures/psychology ; Humans ; Humeral Fractures/economics ; Humeral Fractures/psychology ; Male ; Middle Aged ; Osteoporotic Fractures/economics ; Osteoporotic Fractures/psychology ; Patient Acceptance of Health Care/statistics & numerical data ; Quality of Life ; Quality-Adjusted Life Years ; Russia/epidemiology ; Spinal Fractures/economics ; Spinal Fractures/psychology
    Language English
    Publishing date 2020-03-02
    Publishing country England
    Document type Evaluation Study ; Journal Article
    ZDB-ID 2253231-6
    ISSN 1862-3514 ; 1862-3522
    ISSN (online) 1862-3514
    ISSN 1862-3522
    DOI 10.1007/s11657-020-0699-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top